A combined liquid Hib (PRP-OMPC), hepatitis B, diphtheria, tetanus and whole-cell pertussis vaccine: Controlled studies of immunogenicity and reactogenicity

Vaccine

Volumn 19, Issue 15-16, 2001, Pages 2127-2137

  Nolan, Terry ^a   Hogg, Geoff ^a   Darcy, Mary Ann ^a   Skeljo, Maryanne ^b   Carlin, John ^a   Boslego, John ^c  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CSL LIMITED   (Australia)

^c MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Diphtheria; Hepatitis B; Hib vaccine; Immunogenicity; Pertussis; Tetanus; Vaccine

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B VACCINE; PENTAVAX; PLACEBO; QUADRIVAX; UNCLASSIFIED DRUG;

ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DOSE CALCULATION; DRUG EFFICACY; DRUG FORMULATION; EDEMA; ERYTHEMA; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNOGENICITY; INFANT; INFLUENZA; NORMAL HUMAN; PERTUSSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TETANUS;

AGE FACTORS; ANTIBODIES, BACTERIAL; DIPHTHERIA-TETANUS-PERTUSSIS VACCINE; DOUBLE-BLIND METHOD; HAEMOPHILUS VACCINES; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; IMMUNIZATION SCHEDULE; INFANT; INFANT, NEWBORN; POLYSACCHARIDES, BACTERIAL;

EID: 0035961511     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(00)00403-5     Document Type: Article

References (21)

1. Progress on the control of hepatitis B infection through immunization
2. Hepatitis B virus: A comprehensive strategy for eliminating transmission in the United States through universal childhood immunisation
3. Australia's notifiable diseases status, 1997
4. Immunogenicity and reactogenicity of 2 Hib tetanus conjugate vaccines administered by reconstituting with DTPa or given as separate injections
5. Combination vaccines
6. Combined vaccination of Haemophilus influenzae type b conjugate and diphtheria-tetanus-pertussis containing acellular pertussis
7. A combined liquid Hib (PRP-OMP), hepatitis B, diphtheria, tetanus and whole cell pertussis vaccine: Uncontrolled preliminary clinical trial of immunogenicity and reactogenicity
8. Proving the null hypothesis
9. Defining the key parameters for comparing reactions among acellular and whole-cell pertussis vaccines
10. Comparative immunogenicity of four Haemophilus influenzae type b conjugate vaccines in Alaska Native infants
11. Feasibility study of a combined diphtheria-tetanus-acellular pertussis-hepatitis B (DTPa-HBV) vaccine, and comparison of clinical reactions and immune responses with diphtheria-tetanus-acellular pertussis (DTPa) and hepatitis B vaccines applied as mixed or injected into separate limbs
12. Hepatitis B vaccine alternative vaccination schedules in healthy babies of non-carrier (HbsAg-) mothers
13. HBV vaccine for infants with an alternative schedule
14. Immunogenicity and protective efficacy of low dose recombinant DNA hepatitis B vaccine in normal and high-risk neonates
15. Hepatitis B vaccination of 2367 newborns with different antigenic dosages influence of per-natal factors on the immune response to the vaccine
16. Comparative controlled study of the immunogenicity of two dosing schedules of HB VAX II hepatitis B vaccine in neonates
17. Progress toward elimination of hepatitis B virus transmission in the United States
18. Hepatitis B vaccine
19. Are booster immunisations needed for lifelong hepatitis B immunity?